NCT04800731View on ClinicalTrials.gov

Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19

CompletedOBSERVATIONAL

Enrollment

227

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

LymphopeniaCovid19Older People

Interventions

OTHER

observation no intervention

no intervention

Trial Locations (1)

1090

UZ brussel, Brussels

All Listed Sponsors

lead

Universitair Ziekenhuis Brussel

OTHER